Statistics for Final 192-week efficacy and safety results of the ADVANCE Trial, comparing 3 first-line antiretroviral regimens
Total visits
views | |
---|---|
Final 192-week efficacy and safety results of the ADVANCE Trial, comparing 3 first-line antiretroviral regimens | 12 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 10 |
September 2024 | 1 |
October 2024 | 1 |
November 2024 | 0 |
File Visits
views | |
---|---|
Sokhela_Final_2024.pdf | 15 |
Top country views
views | |
---|---|
South Africa | 9 |
Brazil | 1 |
Japan | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Johannesburg | 8 |
Chiyoda-ku | 1 |
Groblersdal | 1 |
Novosibirsk | 1 |
São Paulo | 1 |